Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects

Clinical trial NCT02300844 · COMPLETED

Trial details

NCT number

NCT02300844

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-12-01

Primary completion

2016-03-21

Enrollment

54

View on ClinicalTrials.gov